Search results

Read about an ANSTO scientist and their work to prepare for a school project or interview.

On the 10th of October 2025, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.

Four annual awards in neutron scattering were announced at Australian Neutron Beam Users Group (ANBUG) and AINSE Neutron Scattering Symposium (AANSS) to individuals with strong links to ANSTO

ANSTO's Sydney locations are home to the Open Pool Australian Light-water (OPAL) multi-purpose reactor, the Centre for Accelerator Science (CAS), the Australian Centre for Neutron Scattering, the National Research Cyclotron and the National Deuteration Facility.

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Meeting of minds about potential next-generation cancer treatment for Australians

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

ANSTO has released the Independent Safety Review of Building 23 - Nuclear medicine production facility.

ANSTO scientist, Dr Klaus Wilcken of the Centre for Accelerator Science, used cosmogenic nuclide dating to determine the ages of layered sand and gravel samples, in which seven footprints of the flightless bird, the moa, were found on the South Island in New Zealand in 2019.

ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.  

A number of sophisticated non-invasive nuclear and accelerator techniques were used to provide information about the origin and age of an Australian Aboriginal knife held in the collection of the Powerhouse Museum.

Understanding of the role that programmed cell death has in development.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.